RENSSELAER, N.Y., Oct. 26 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2 virus, which causes COVID-19, uses the ACE2 receptor to enter cells. Due to differences between the mouse and human ACE2 receptors, normal laboratory mice [...]
RENSSELAER, N.Y., June 10 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces local West Coast United States production of the immunodeficient CIEA NOG mouse® model. Immunodeficient animal models are critical to the drug discovery ecosystem. One of the most common contributors to the high product attrition rate for [...]
RENSSELAER, N.Y., May 18 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid Restart™ program. Launched over a month ago, Taconic was the first animal model provider in the industry to provide researchers with a program specifically designed to aid laboratories transitioning [...]
RENSSELAER, N.Y., March 20 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces support for global COVID-19 research efforts via a new Coronavirus Toolkit featuring relevant models and services. Mouse models have been extensively used for research on the SARS-CoV virus, closely related to the new SARS-CoV-2 virus that causes [...]
RENSSELAER, N.Y., Feb. 14 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces its humanized immune system mice models are now being produced in Europe. Local production provides European drug discovery researchers with easier access to this critical oncology research tool. Humanized immune system mice enable drug discovery [...]
RENSSELAER, N.Y., Jan. 31 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its premier immuno-oncology portfolio with the launch of the new B2m-NOG mouse model. Immuno-oncology leverages the body’s immune system to fight cancer, increasing the ability to target the disease. Animal models used in this therapeutic development [...]
RENSSELAER, N.Y., Jan. 2 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the availability of both commercial animal model production and colony management services through a new location in San Diego. Taconic can now provide critical drug discovery research solutions locally to west coast customers. The new [...]
RENSSELAER, N.Y., Nov. 4 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer’s disease model, the ARTE10 mouse model. Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes. This combination manifests [...]
RENSSELAER, N.Y., Oct. 17 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the addition of Frank Sistare, PhD to its Scientific Advisory Board (SAB). Dr. Sistare joins existing SAB members Andrew Goodman, PhD, David Hill, PhD, and Robert Rosenthal, PhD. The SAB will continue to collaborate with [...]
RENSSELAER, N.Y., Sept. 3 (Korea Bizwire) — Taconic Biosciences, a global leader in providing genetically engineered animal model solutions, announces its participation in the second Rodent Research Reference mission to the International Space Station. Taconic has a history with NASA dating back to 1985. While previous NASA programs were collaborations with academic and/or commercial organizations [...]